Balancing Stroke Prevention and Bleeding Risk in Atrial Fibrillation

Managing atrial fibrillation requires carefully weighing stroke prevention against the risk of bleeding. Patients with a CHA2DS2-VASc score of 3 benefit from anticoagulation, but concerns about bleeding often influence decision-making. Clear communication, shared decision-making, and individualized therapy are key to optimal outcomes. Scroll down and share the most complex AF patient case you’ve managed —how did you counsel them on stroke prevention and bleeding risk? Your insights could help other clinicians navigate challenging scenarios.

##Reference## January CT, et al. 2019 AHA/ACC/HRS Focused Update on Atrial Fibrillation. Circulation. 2019;140:e125–e151.## ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability, reliability, or adequacy of…